Truist: 'We remain bullish on AdaptHealth (AHCO) post management meetings'
Truist Securities analyst David MacDonald reiterated a Buy rating and $14.00 price target on AdaptHealth (NASDAQ: AHCO).The analyst commented: "We ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
